Pure Biologics (Poland) Market Value
| PUR Stock | 14.00 0.22 1.60% |
| Symbol | Pure |
Pure Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pure Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pure Biologics.
| 11/15/2024 |
| 12/15/2024 |
If you would invest 0.00 in Pure Biologics on November 15, 2024 and sell it all today you would earn a total of 0.00 from holding Pure Biologics Splka or generate 0.0% return on investment in Pure Biologics over 30 days.
Pure Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pure Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pure Biologics Splka upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 22.43 | |||
| Value At Risk | (6.82) | |||
| Potential Upside | 6.18 |
Pure Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pure Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pure Biologics' standard deviation. In reality, there are many statistical measures that can use Pure Biologics historical prices to predict the future Pure Biologics' volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.60) | |||
| Total Risk Alpha | (1.25) | |||
| Treynor Ratio | 0.6337 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pure Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pure Biologics Splka Backtested Returns
Pure Biologics Splka maintains Sharpe Ratio (i.e., Efficiency) of -0.14, which implies the firm had a -0.14% return per unit of risk over the last 3 months. Pure Biologics Splka exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pure Biologics' Risk Adjusted Performance of (0.11), variance of 19.3, and Coefficient Of Variation of (632.84) to confirm the risk estimate we provide. The company holds a Beta of -1.11, which implies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Pure Biologics are expected to decrease slowly. On the other hand, during market turmoil, Pure Biologics is expected to outperform it slightly. At this point, Pure Biologics Splka has a negative expected return of -0.63%. Please make sure to check Pure Biologics' maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Pure Biologics Splka performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.46 |
Average predictability
Pure Biologics Splka has average predictability. Overlapping area represents the amount of predictability between Pure Biologics time series from 15th of November 2024 to 30th of November 2024 and 30th of November 2024 to 15th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pure Biologics Splka price movement. The serial correlation of 0.46 indicates that about 46.0% of current Pure Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | 0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 3.0 |
Pure Biologics Splka lagged returns against current returns
Autocorrelation, which is Pure Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pure Biologics' stock expected returns. We can calculate the autocorrelation of Pure Biologics returns to help us make a trade decision. For example, suppose you find that Pure Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pure Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pure Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pure Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pure Biologics stock over time.
Current vs Lagged Prices |
| Timeline |
Pure Biologics Lagged Returns
When evaluating Pure Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pure Biologics stock have on its future price. Pure Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pure Biologics autocorrelation shows the relationship between Pure Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in Pure Biologics Splka.
Regressed Prices |
| Timeline |
Pair Trading with Pure Biologics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pure Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pure Biologics will appreciate offsetting losses from the drop in the long position's value.Moving together with Pure Stock
Moving against Pure Stock
| 0.73 | DNP | Dino Polska SA | PairCorr |
| 0.63 | SAN | Banco Santander SA | PairCorr |
| 0.61 | CEZ | CEZ as | PairCorr |
| 0.35 | UCG | UniCredit SpA | PairCorr |
The ability to find closely correlated positions to Pure Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pure Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pure Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pure Biologics Splka to buy it.
The correlation of Pure Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pure Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pure Biologics Splka moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pure Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Pure Stock Analysis
When running Pure Biologics' price analysis, check to measure Pure Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pure Biologics is operating at the current time. Most of Pure Biologics' value examination focuses on studying past and present price action to predict the probability of Pure Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pure Biologics' price. Additionally, you may evaluate how the addition of Pure Biologics to your portfolios can decrease your overall portfolio volatility.